NCT03990766View on ClinicalTrials.gov

Smell Changes & Efficacy of Nasal Theophylline

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 15, 2019

Primary Completion Date

January 15, 2021

Study Completion Date

January 15, 2021

Conditions
Olfactory DisorderAnosmiaViral InfectionTheophylline Causing Adverse Effects in Therapeutic UseSmell Disorder
Interventions
DRUG

Theophylline

Theophylline delivered via high-volume, low-pressure nasal saline irrigation

DRUG

Saline Nasal

Lactose delivered via high-volume, low-pressure nasal saline irrigation

Trial Locations (1)

63110

Washington University in St. Louis, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT03990766 - Smell Changes & Efficacy of Nasal Theophylline | Biotech Hunter | Biotech Hunter